Sympathetic Ophthalmia in Western India - All India ...
Sympathetic Ophthalmia in Western India - All India ...
Sympathetic Ophthalmia in Western India - All India ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
606 AIOC 2009 PROCEEDINGS<br />
AUTHORS’S PROFILE:<br />
DR. VINITA GIRISH RAO: M.B.B.S., Calcutta National Medical College, Calcutta, West<br />
Bengal; M.S., Post graduation <strong>in</strong> Ophthalmology (DNB) from Sankar Nethralaya, Chennai,<br />
1998; Fellowship <strong>in</strong> General Ophthalmology, Sankara Nethralaya, Chennai, 1997-’98. Presently,<br />
Senior consultant, Department of Cataract, Uveitis and Glaucoma, Shri Ganapati Netralaya,<br />
Jalna , Maharashtra. Founder member of the executive committee of the USI.<br />
E-mail: vnair@netralaya.org<br />
<strong>Sympathetic</strong> <strong>Ophthalmia</strong> <strong>in</strong> <strong>Western</strong> <strong>India</strong><br />
<strong>Sympathetic</strong> <strong>Ophthalmia</strong> (SO) is a bilateral<br />
granulomatous panuveitis which occurs after<br />
a penetrat<strong>in</strong>g <strong>in</strong>jury that <strong>in</strong>volves the uveal<br />
tissue. Although the exact pathogenesis is<br />
unknown, the hypothesis of an autoimmune<br />
disease has received <strong>in</strong>creas<strong>in</strong>g support. Steroids<br />
and immunosuppressives form the ma<strong>in</strong>stay of<br />
treatment and the visual outcome has been<br />
variable. There are few <strong>India</strong>n studies 3,4 which<br />
assess the visual outcome <strong>in</strong> our patients and this<br />
study was undertaken to assess the prognosis <strong>in</strong><br />
these patients.<br />
Materials and Methods<br />
23 patients of sympathetic ophthalmia (SO), were<br />
seen at our referral <strong>in</strong>stitute based <strong>in</strong><br />
Maharashtra, between Jan 2000 and Jan 2008. The<br />
patients were identified from a computerized<br />
database and their records were analysed<br />
retrospectively. The records were analysed for<br />
the age, sex and occupation of the patient, the<br />
type of <strong>in</strong>jury susta<strong>in</strong>ed, the <strong>in</strong>terval from the<br />
<strong>in</strong>jury to the onset of symptoms and <strong>in</strong>terval<br />
from onset of symptoms to presentation at our<br />
cl<strong>in</strong>ic. <strong>All</strong> the patients were exam<strong>in</strong>ed by slitlamp<br />
and <strong>in</strong>direct ophthalmoscopy , and wherever<br />
required ancillary <strong>in</strong>vestigations were done.<br />
Diagnosis was made on the basis of history,<br />
cl<strong>in</strong>ical features and test results.<br />
Results<br />
Of the 23 patients of SO, 13 were males and 10<br />
were females. 15 patients (69.57%) were <strong>in</strong> the<br />
age group 21- 55 yrs, 3 patients (13.04%) were<br />
20yrs or lesser and 5 patients (21.74%) were more<br />
than 55 yrs of age. In 21 patients (91.30%) the<br />
cause was penetrat<strong>in</strong>g <strong>in</strong>jury and <strong>in</strong> 2 patients<br />
there was blunt trauma. The most common cause<br />
of penetrat<strong>in</strong>g <strong>in</strong>jury was accidental trauma <strong>in</strong> 16<br />
Dr. V<strong>in</strong>ita Rao, Dr. Girish Rao<br />
(Present<strong>in</strong>g Author: Dr. V<strong>in</strong>ita Rao)<br />
(69.57%) of the 23 patients. In 5 patients it<br />
occurred after ocular surgery. 2 patients were<br />
significant <strong>in</strong> that the SO occurred secondary to<br />
perforated corneal ulcer and one of them<br />
developed the <strong>in</strong>flammation after evisceration.<br />
SO occurred most commonly between 2weeks to<br />
3 months after <strong>in</strong>jury (14 patients – 60.87%). In 6<br />
patients it occurred between 3 months and 1 year<br />
and <strong>in</strong> 3 patients more than a year after <strong>in</strong>jury. In<br />
no patient the <strong>in</strong>flammation was seen to occur<br />
with<strong>in</strong> 2 weeks of the <strong>in</strong>jury. The earliest<br />
occurrence of SO was seen with<strong>in</strong> 21 days of the<br />
<strong>in</strong>jury and the latest after 96 months.<br />
14 patients presented to our cl<strong>in</strong>ic with<strong>in</strong> 2 weeks<br />
of development of symptoms. 1 patient with<strong>in</strong><br />
one month, 5 patients between 1 month and 3<br />
months and 3 patients after 3months from onset<br />
of symptoms. Of the 14 patients who presented<br />
early 2 had no light perception <strong>in</strong> both the<br />
excit<strong>in</strong>g and the sympathiz<strong>in</strong>g eye. 2 others who<br />
had no light perception <strong>in</strong> the excit<strong>in</strong>g eye,<br />
underwent enucleation . Other 10 eyes had a<br />
vision of count<strong>in</strong>g f<strong>in</strong>gers close to face at least<br />
and hence were not considered for early<br />
enucleation.<br />
The vision <strong>in</strong> the excit<strong>in</strong>g eye was less than 6/60<br />
<strong>in</strong> 12 eyes (52.17%) and the rema<strong>in</strong><strong>in</strong>g 11 eyes<br />
(47.83%) had no light perception at presentation<br />
when the other eye developed sympathetic<br />
ophthalmia. The vision <strong>in</strong> the symapthis<strong>in</strong>g eye<br />
was less than 6/60 <strong>in</strong> 14 eyes (60.87%), between<br />
6/18 and 6/60 <strong>in</strong> 5 eyes and 6/12 or better <strong>in</strong> 4<br />
eyes. There was no anterior segment<br />
<strong>in</strong>flammation <strong>in</strong> 4 eyes and 2 eyes had<br />
granulomatous anterior uveitis while the rest had<br />
nongranulomatous anterior uveitis. Vitritis was<br />
absent <strong>in</strong> 3 eyes and <strong>in</strong> one eye it was m<strong>in</strong>imal.<br />
21 of the 23 eyes had ret<strong>in</strong>al detachment at
UVEA SESSION<br />
607<br />
presentation of which 7 had bullous ret<strong>in</strong>al<br />
detachment. In the rema<strong>in</strong><strong>in</strong>g 2 patients, there<br />
was chronic uveitis, attached ret<strong>in</strong>a and a sunset<br />
glow fundus. 12 of the 23 eyes had disc<br />
hyperaemia. The typical sunset glow fundus with<br />
peripheral RPE defects was present <strong>in</strong> 7 eyes. In<br />
5 eyes there were Dalen-Fuch’s nodules.<br />
Systemic features were seen <strong>in</strong> 5 patients, which<br />
<strong>in</strong>cluded headache and neck ache (5), vertigo (1)<br />
and t<strong>in</strong>nitus and hear<strong>in</strong>g loss (3) and alopecia (1)<br />
Fluoresce<strong>in</strong> angiography was done <strong>in</strong> 4 patients<br />
and all of them showed early leaks with late<br />
pool<strong>in</strong>g of the dye. In other patients the<br />
fluoresce<strong>in</strong> angiography was omitted due to the<br />
vitritis or the diagnostic cl<strong>in</strong>ical picture.<br />
Ultrasonography showed a diffuse choroidal<br />
thicken<strong>in</strong>g of average 2.6mm.<br />
<strong>All</strong> patients were treated with systemic steroids.<br />
In addition 7 patients received IV methyl<br />
prednisolone at presentation with sympathetic<br />
ophthalmia. Dur<strong>in</strong>g the course of treatment 12<br />
patients needed immunosuppressive treatment<br />
either <strong>in</strong> addition or as a switchover. The<br />
immunosuppressive used <strong>in</strong> all patients was oral<br />
azathiopr<strong>in</strong>e tablets. The average duration of<br />
treatment was 6.65 months <strong>in</strong>clud<strong>in</strong>g those who<br />
were lost to follow up.<br />
The commonest complication was partial or<br />
complete optic atrophy which was seen <strong>in</strong> 11<br />
eyes. Cataract was seen <strong>in</strong> 6 eyes of which 3 eyes<br />
underwent phacoemulsification with <strong>in</strong>traocular<br />
lens implantation with a good visual outcome. 3<br />
eyes developed glaucoma, which was managed<br />
medically. 2 eyes developed subret<strong>in</strong>al fibrosis<br />
and 1 eye developed recurrent neovascularisation<br />
of the disc and repeated vitreous<br />
haemorrhage and had to undergo vitrectomy and<br />
endolaser photocoagulation.<br />
The f<strong>in</strong>al vision <strong>in</strong> the sympathetic eye was 6/12<br />
or better <strong>in</strong> 12 eyes, between 6/18 to 6/60 <strong>in</strong> 2<br />
eyes and less than 6/60 <strong>in</strong> 9 eyes. <strong>All</strong> the 9 eyes<br />
which had vision less than 6/60, had optic<br />
atrophy either due to severe <strong>in</strong>flammation or<br />
due to <strong>in</strong>adequate treatment .In addition 2 eyes<br />
<strong>in</strong> the same group had subret<strong>in</strong>al fibrosis.<br />
Discussion<br />
The result of the present study broadly agrees<br />
with previous studies <strong>in</strong> the literature. 1,2 A<br />
marg<strong>in</strong>al male predom<strong>in</strong>ance seen <strong>in</strong> our series<br />
is probably because ocular trauma is the<br />
occupational hazard associated with outdoor<br />
work and manual labor and our <strong>in</strong>stitute caters<br />
to a population who are predom<strong>in</strong>antly farmers.<br />
SO occurs more often after accidental <strong>in</strong>jury<br />
rather than planned surgery. Hence we saw a<br />
predom<strong>in</strong>ance of this condition <strong>in</strong> the age group<br />
of 20-60 years which aga<strong>in</strong> has the maximum<br />
number of young work<strong>in</strong>g adults.<br />
The typical presentation of SO is a bilateral<br />
panuveitis that occurs after ocular trauma or<br />
<strong>in</strong>traocular surgery. 1 There is circumciliary<br />
congestion, keratic precipitates, posterior<br />
synechiae, vitritis, choroidal <strong>in</strong>filtration,<br />
vasculitis, disc oedema and exudative ret<strong>in</strong>al<br />
detachment. Although panuveitis is common, 1<br />
there are <strong>in</strong>stances when SO presents with just<br />
posterior segment <strong>in</strong>flammation, 4 which was the<br />
case with 4 patients <strong>in</strong> our series. It was believed<br />
earlier, that purulent endophthalmitis would<br />
destroy uveal antigens to such an extent that SO<br />
would not occur, but more recent studies 3 have<br />
proven histopathologically that it could occur. In<br />
our series we had 2 cases of SO occurr<strong>in</strong>g after<br />
perforated corneal ulcers lead<strong>in</strong>g to<br />
endophthalmitis and then SO. In one,<br />
evisceration was performed at our <strong>in</strong>stitute and<br />
the SO developed 2weeks after the evisceration.<br />
It is also important to note that we had 2 cases of<br />
blunt trauma <strong>in</strong> our series. We looked closely for<br />
any signs of occult penetrat<strong>in</strong>g <strong>in</strong>jury but could<br />
not f<strong>in</strong>d any. Systemic features are rarely<br />
associated with SO 1 , but <strong>in</strong> our series 5 patients<br />
had extraocular symptoms. Although classically<br />
SO is associated with granulomatous uveitis, we<br />
have seen more cases present<strong>in</strong>g with non<br />
granulomatous uveitis. There are reports of SO<br />
present<strong>in</strong>g with just posterior segment<br />
<strong>in</strong>flammation, without panuveitis 4 which has<br />
been our observation <strong>in</strong> the present series <strong>in</strong> 4<br />
cases. The cl<strong>in</strong>ical picture may sometimes closely<br />
resemble Vogt-Koyanagi- Harada disease and<br />
<strong>in</strong> the absence of histopathological confirmation,<br />
presence of penetrat<strong>in</strong>g <strong>in</strong>jury may be the only<br />
differentiat<strong>in</strong>g feature of SO. Previously, SO was<br />
considered to be a dreaded disease, but <strong>in</strong> our<br />
series as well as <strong>in</strong> the other recent studies 1,4 it<br />
has been seen that if treated early and<br />
adequately, it has a good visual outcome. This is<br />
because of the rapid onset of optic atrophy <strong>in</strong><br />
<strong>in</strong>adequate treatment or <strong>in</strong> fulm<strong>in</strong>ant disease.
608 AIOC 2009 PROCEEDINGS<br />
One of the rarer complications we noted was the<br />
recurrent vitreous hemorrhage due to<br />
neovascularisation of the disc <strong>in</strong> one of our<br />
patients <strong>in</strong> this series and it has also been noted<br />
by Sampangi 5 et al <strong>in</strong> a recent study. We have<br />
also shown that cataract surgery and <strong>in</strong>traocular<br />
1. Chi-Chao Chan, Roberge FG,WhitcupSM,<br />
NussenblattRB. 32 cases of sympathetic<br />
ophthalmia. Arch Ophthalmol. 1995;113:597-600.<br />
2. Jenn<strong>in</strong>gs T, TesslerHH. Twenty cases of<br />
sympathetic ophthalmia . Br J ophthalmol 1989;73:<br />
140-5.<br />
3. Rath<strong>in</strong>am SR, Rao NA. <strong>Sympathetic</strong> ophthalmia<br />
follow<strong>in</strong>g postoperative bacterial endophthalmitis:<br />
References<br />
lens is a safe option <strong>in</strong> these patients.<br />
This study shows that it is possible to achieve<br />
good visual outcome (52.17% -6/12 or better) <strong>in</strong><br />
SO provided an early diagnosis and thereby<br />
adequate treatment is started.<br />
a cl<strong>in</strong>icopathologic study.<br />
4. Gupta V, Gupta A, Dogra MR. Posterior<br />
sympathetic ophthalmia : a s<strong>in</strong>gle centre study of 40<br />
patients from north <strong>India</strong>. Eye. 2007.<br />
5. Sampangi R, Venkatesh P, Mandal S, Garg SP.<br />
Recurrent neovascularization of the disc <strong>in</strong><br />
sympathetic ophthalmia. <strong>India</strong>n J Ophthalmol. 2008;<br />
56:232-4.